NCT05551338

Brief Summary

IMPORTANCE: Rehabilitation games have been shown to improve cognitive function among people with various disorders but they have not been explored in home settings for patients with Parkinson's disease. OBJECTIVE: To collect pilot data regarding the therapeutic benefits of self-administered rehabilitation games among patients with Parkinson's disease. METHODS: The investigators will recruit 20 patients with Parkinson's disease into a pilot randomized controlled trial. Patients will be asked to perform two 30-minute sessions per week of training using serious games over a 3-month period in addition to conventional care or undergo only usual care. Patients will be evaluated at baseline, after 12 weeks of treatment, and at 24 weeks. Improvements in cognitive function, depression, quality of life, and mobility will be assessed. RELEVANCE: Identifying whether self-administered rehabilitation games can lead to clinical improvements could have significant implications for the management of the disease.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at P25-P50 for not_applicable parkinson-disease

Timeline
Completed

Started Jun 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 15, 2022

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

June 21, 2022

Completed
3 months until next milestone

First Posted

Study publicly available on registry

September 22, 2022

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

September 22, 2022

Status Verified

September 1, 2022

Enrollment Period

1.5 years

First QC Date

June 21, 2022

Last Update Submit

September 19, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • Montreal Cognitive Assessment (MoCA)

    The Montreal Cognitive Assessment is a widely used test of cognitive function among the elderly; it includes tests of orientation, attention, memory, language and visual-spatial skills. The minimum score is 0 the maximum score is 30. Higher scores indicate higher cognitive function and lower scores indicate lower cognitive function.

    Baseline (week 0)

  • Montreal Cognitive Assessment (MoCA)

    The Montreal Cognitive Assessment is a widely used test of cognitive function among the elderly; it includes tests of orientation, attention, memory, language and visual-spatial skills. The minimum score is 0 the maximum score is 30. Higher scores indicate higher cognitive function and lower scores indicate lower cognitive function.

    Post-intervention (week 12)

  • Montreal Cognitive Assessment (MoCA)

    The Montreal Cognitive Assessment is a widely used test of cognitive function among the elderly; it includes tests of orientation, attention, memory, language and visual-spatial skills. The minimum score is 0 the maximum score is 30. Higher scores indicate higher cognitive function and lower scores indicate lower cognitive function.

    Follow-up (week 24)

Secondary Outcomes (6)

  • Digit span forward and backward

    Baseline (week 0), Post-intervention (week 12), Follow-up (week 24)

  • Semantic fluency test

    Baseline (week 0), Post-intervention (week 12), Follow-up (week 24)

  • Geriatric depression scale

    Baseline (week 0), Post-intervention (week 12), Follow-up (week 24)

  • LifeSpace Assessment

    Baseline (week 0), Post-intervention (week 12), Follow-up (week 24)

  • PDQ-39

    Baseline (week 0), Post-intervention (week 12), Follow-up (week 24)

  • +1 more secondary outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

Patients will be asked to perform two 30-minute sessions per week of training using serious games over a 3-month period in their home setting in addition to their conventional care

Other: Serious games

Control

NO INTERVENTION

Patients will undergo only their conventional care

Interventions

The training protocol will entail using a tablet-based program that includes 6 serious games. Patients will be asked to use the program twice a week for 3 months. The serious games that will be used in this study were developed to challenge short-term memory and selective attention in six different games. Each of the six games comprise 20 different stages of varying difficulty, where stage 1 is the easiest and stage 20 is the most difficult.

Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of mild to moderate PD (Hoehn \& Yahr 1-3)
  • baseline MoCA score \<26
  • ≥ 18 years-old
  • ability to communicate and read in English
  • have self-reported technological literacy (ie answer yes to the question asking if they are comfortable using technological devices)

You may not qualify if:

  • comorbid conditions that could affect the performance of the tasks (e.g. severe uncorrected vision impairment)
  • severe cognitive impairment that would prevent the patient from understanding the tasks (MoCA\<16)
  • if the subject does not want to be video recorded during the assessments or interview sessions
  • if the subject does not have access to WiFi

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rutgers University

Newark, New Jersey, 07107, United States

RECRUITING

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Central Study Contacts

Jean-Francois Daneault

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcome assessors will be blinded to participant assignment.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Group 1: 10 patients will be asked to perform two 30-minute sessions per week of training using serious games over a 3-month period in addition to their conventional care. Group 2: 10 patients will only receive their conventional care.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

June 21, 2022

First Posted

September 22, 2022

Study Start

June 15, 2022

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

September 22, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will share

Following the completion of this study, the deidentified data set resulting from this body of work will be added to an open source data bank for use by future researchers.

Shared Documents
ANALYTIC CODE
Time Frame
The data will become available after study completion. Data availability will be indefinite as it will be posted on a data repository.

Locations